Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Neurooncol. 2014 May;118(1):193–199. doi: 10.1007/s11060-014-1420-7

Table 1.

Participant Demographic and Clinical Characteristics

Brain Tumor (N=50) Siblings (N=39) Solid Tumor (N=40) p
Gender (% Male) 50 51.3 50 0.99
Age at Diagnosis (Y) 6.38 ± 3.43 NA 4.50 ± 4.18 0.02*
Time from Diagnosis to CRT (Y) 1.14 ± 1.86 NA NA NA
Age at Assessment (Y) 13.18 ± 2.88 12.98 ± 2.61 13.21 ± 3.46 0.93
Time since Diagnosis (Y) 6.80 ± 2.60 NA 8.71 ± 3.94 <0.01*
SES (BSMSS) 37.61 ± 12.20 42.71 ± 12.19 42.09 ± 13.32 0.11
Abbreviated IQ (WASI std score) 98.20 ± 13.91 108.59 ± 12.68 107.88 ± 12.44 <0.01*

P-value indicates whether group is equally distributed across sub-categories using One-Way ANOVA, independent t-test or Chi-square. Y – Years; CRT – conformal radiation therapy; SES – socioeconomic status; BSMSS - Barratt Simplified Measure of Social Status (Scores range from 8 to 66 with higher scores indicative of higher SES); IQ – intelligence quotient; WASI – Wechsler Abbreviated Scale of Intelligence